Huadong Medicine Co., Ltd
000963
Rang in Aktien
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Aktienkurs
$3.89
Marktkapitalisierung
$6.83B
Veränderung (1 Tag)
-2.22%
Veränderung (1 Jahr)
-30.58%
Land
CN
Handel Huadong Medicine Co., Ltd (000963)
Kategorie
Healthcare
EPS für Huadong Medicine Co., Ltd (000963)
EPS zum June 2026 TTM: $0.30
Laut den aktuellen Finanzberichten und dem Aktienkurs von Huadong Medicine Co., Ltd beträgt das aktuelle EPS des Unternehmens (TTM) $0.30. Am Ende des Jahres 2024 betrug das EPS $0.28 eine Steigerung gegenüber dem EPS von 2023, das $0.23 betrug.
EPS-Verlauf von Huadong Medicine Co., Ltd von 2001 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $0.30 | 5.36% |
| 2025 | $0.28 | 1.20% |
| 2024 | $0.28 | 20.31% |
| 2023 | $0.23 | 10.42% |
| 2022 | $0.21 | -0.19% |
| 2021 | $0.21 | -15.74% |
| 2020 | $0.25 | 6.62% |
| 2019 | $0.23 | 23.31% |
| 2018 | $0.19 | 19.58% |
| 2017 | $0.16 | 31.21% |
| 2016 | $0.12 | 10.85% |
| 2015 | $0.11 | 39.10% |
| 2014 | $0.08 | 27.05% |
| 2013 | $0.06 | 26.82% |
| 2012 | $0.05 | 26.25% |
| 2011 | $0.04 | 25.74% |
| 2010 | $0.03 | -13.92% |
| 2009 | $0.04 | 118.63% |
| 2008 | $0.02 | 6.62% |
| 2007 | $0.02 | 69.66% |
| 2006 | $0.01 | 45.90% |
| 2005 | $0.01 | 221.05% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | -34.48% |
| 2002 | 0.00 | -12.12% |
| 2001 | 0.00 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| $0.72 | 145.12% |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 88.58% |
IN
|
